| Dr Michael Eun Suk Bang, MD | |
|
401 Matthew St, Hospitalists, Marietta, OH 45750-1635 | |
| (740) 374-7700 | |
| (740) 374-7701 |
| Full Name | Dr Michael Eun Suk Bang |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 401 Matthew St, Marietta, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245349463 | NPI | - | NPPES |
| 2367362 | Medicaid | OH | |
| P01464910 | Other | OH | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 35081558 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesis Hospital | Zanesville, OH | Hospital |
| Riverside Methodist Hospital | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Ohio Hospitalists, Inc | 7810985686 | 171 |
News Archive
Engineers at the University of California San Diego have developed the first flexible wearable device capable of monitoring both biochemical and electric signals in the human body.
By coaxing healthy and diseased human bone marrow to become embryonic-like stem cells, a team of Wisconsin scientists has laid the groundwork for observing the onset of the blood cancer leukemia in the laboratory dish.
A new study published on the preprint server bioRxiv in November 2020 describes the virus's N protein as a promising epitope for serology.
Pfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of advanced kidney cancer, after failure of prior treatment with sunitinib or a cytokine.
Allenex AB: Net sales for the first six months were SEK 44.9 million (41.5), an increase of 8.2%.
› Verified 7 days ago
| Entity Name | Central Ohio Hospitalists, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659455145 PECOS PAC ID: 7810985686 Enrollment ID: O20040503000515 |
News Archive
Engineers at the University of California San Diego have developed the first flexible wearable device capable of monitoring both biochemical and electric signals in the human body.
By coaxing healthy and diseased human bone marrow to become embryonic-like stem cells, a team of Wisconsin scientists has laid the groundwork for observing the onset of the blood cancer leukemia in the laboratory dish.
A new study published on the preprint server bioRxiv in November 2020 describes the virus's N protein as a promising epitope for serology.
Pfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of advanced kidney cancer, after failure of prior treatment with sunitinib or a cytokine.
Allenex AB: Net sales for the first six months were SEK 44.9 million (41.5), an increase of 8.2%.
› Verified 7 days ago
| Entity Name | Genesis Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063663433 PECOS PAC ID: 7719040385 Enrollment ID: O20090107000547 |
News Archive
Engineers at the University of California San Diego have developed the first flexible wearable device capable of monitoring both biochemical and electric signals in the human body.
By coaxing healthy and diseased human bone marrow to become embryonic-like stem cells, a team of Wisconsin scientists has laid the groundwork for observing the onset of the blood cancer leukemia in the laboratory dish.
A new study published on the preprint server bioRxiv in November 2020 describes the virus's N protein as a promising epitope for serology.
Pfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of advanced kidney cancer, after failure of prior treatment with sunitinib or a cytokine.
Allenex AB: Net sales for the first six months were SEK 44.9 million (41.5), an increase of 8.2%.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Eun Suk Bang, MD Po Box 449, Marietta, OH 45750-0449 Ph: (740) 374-4500 | Dr Michael Eun Suk Bang, MD 401 Matthew St, Hospitalists, Marietta, OH 45750-1635 Ph: (740) 374-7700 |
News Archive
Engineers at the University of California San Diego have developed the first flexible wearable device capable of monitoring both biochemical and electric signals in the human body.
By coaxing healthy and diseased human bone marrow to become embryonic-like stem cells, a team of Wisconsin scientists has laid the groundwork for observing the onset of the blood cancer leukemia in the laboratory dish.
A new study published on the preprint server bioRxiv in November 2020 describes the virus's N protein as a promising epitope for serology.
Pfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of advanced kidney cancer, after failure of prior treatment with sunitinib or a cytokine.
Allenex AB: Net sales for the first six months were SEK 44.9 million (41.5), an increase of 8.2%.
› Verified 7 days ago
Sujeeth K Shetty, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 401 Matthew St, Marietta, OH 45750 Phone: 740-376-1994 Fax: 740-374-7701 | |
Robert L Behnke, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 401 Matthew St, Marietta, OH 45750 Phone: 740-376-1994 Fax: 740-374-7701 | |
Michelle Dawn Caldwell, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 401 Matthew St, Marietta, OH 45750 Phone: 740-374-7700 | |
Hayden Tran, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 401 Matthew St, Marietta, OH 45750 Phone: 740-376-1994 Fax: 740-374-7701 | |
Joseph Agyepong, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 401 Matthew St, Marietta, OH 45750 Phone: 740-376-1994 Fax: 740-374-7701 | |
Gharanai Abdul Payind, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 401 Matthew St, Marietta, OH 45750 Phone: 740-374-7700 Fax: 740-374-7701 |